HD-OPM Archive
Topics › Heart rhythm & heart failure

DECAF trial: continuing coffee cut AF recurrence after cardioversion, 47% vs 64%

Louis Nervegna · Nov 11, 2025 · ♥ 7 reactions · 2 comments · original Facebook post
Heart rhythm & heart failureNuts, fish, coffee, tea, cocoa & other foods
AI summary & key facts

A shared summary of the DECAF randomized trial in 200 habitual coffee drinkers with persistent atrial fibrillation or flutter after cardioversion. Those who kept drinking caffeinated coffee had fewer recurrences over 6 months than those who abstained, with no safety concerns, though the result does not justify starting coffee.

#coffeeHD #afibHD

Research cited

For decades, patients with AF have been told to avoid coffee. A new randomized trial suggests that advice may be outdated.

The DECAF Trial (PMID: 41206802)
200 habitual coffee drinkers with persistent AF or atrial flutter were randomized for 6 months after electrical cardioversion to:

☕ Continue ≥1 cup of caffeinated coffee/day
🚫 Abstain from all coffee and caffeine

Results:
AF or flutter recurred in 47% of coffee drinkers vs 64% of abstainers (a 39% lower hazard of recurrence).
Importantly, no safety concerns were reported.

Why this is actually relevant:
These were long-term, heavy consumers (~7 cups/week) with existing rhythm disorders. The study doesn’t justify starting or increasing caffeine intake, especially for those who’ve had adverse responses.

Possible reasons coffee helped:

For habitual drinkers with AF, moderate coffee intake appears physiologically neutral or even protective. Guidance should be individualized, but the old blanket ban on coffee is losing scientific support.

No photo description available.
← newer: Personalized vitamin D3 dosing halved repeat heart attacks iolder: Statins activate AMPK, the same longevity pathway as metform →